The role of ventricular–arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association

Ventricular–arterial coupling (VAC) plays a major role in the physiology of cardiac and aortic mechanics, as well as in the pathophysiology of cardiac disease. VAC assessment possesses independent diagnostic and prognostic value and may be used to refine riskstratification and monitor therapeutic in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:European journal of heart failure Ročník 21; číslo 4; s. 402 - 424
Hlavní autoři: Ikonomidis, Ignatios, Aboyans, Victor, Blacher, Jacque, Brodmann, Marianne, Brutsaert, Dirk L., Chirinos, Julio A., De Carlo, Marco, Delgado, Victoria, Lancellotti, Patrizio, Lekakis, John, Mohty, Dania, Nihoyannopoulos, Petros, Parissis, John, Rizzoni, Damiano, Ruschitzka, Frank, Seferovic, Petar, Stabile, Eugenio, Tousoulis, Dimitrios, Vinereanu, Dragos, Vlachopoulos, Charalambos, Vlastos, Dimitrios, Xaplanteris, Panagiotis, Zimlichman, Reuven, Metra, Marco
Médium: Journal Article
Jazyk:angličtina
Vydáno: Oxford, UK John Wiley & Sons, Ltd 01.04.2019
European Society of Cardiology (Wiley)
Wiley-Blackwell
Témata:
ISSN:1388-9842, 1879-0844, 1879-0844
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Ventricular–arterial coupling (VAC) plays a major role in the physiology of cardiac and aortic mechanics, as well as in the pathophysiology of cardiac disease. VAC assessment possesses independent diagnostic and prognostic value and may be used to refine riskstratification and monitor therapeutic interventions. Traditionally, VAC is assessed by the non‐invasive measurement of the ratio of arterial (Ea) to ventricular end‐systolic elastance (Ees). With disease progression, both Ea and Ees may become abnormal and the Ea/Ees ratio may approximate its normal values. Therefore, the measurement of each component of this ratio or of novel more sensitive markers of myocardial (e.g. global longitudinal strain) and arterial function (e.g. pulse wave velocity) may better characterize VAC. In valvular heart disease, systemic arterial compliance and valvulo–arterial impedance have an established diagnostic and prognostic value and may monitor the effects of valve replacement on vascular and cardiac function. Treatment guided to improve VAC through improvement of both or each one of its components may delay incidence of heart failure and possibly improve prognosis in heart failure. In this consensus document, we describe the pathophysiology, the methods of assessment as well as the clinical implications of VAC in cardiac diseases and heart failure. Finally, we focus on interventions that may improve VAC and thus modify prognosis.
Bibliografie:SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-4
ObjectType-Conference-2
content type line 23
ObjectType-Article-3
scopus-id:2-s2.0-85062878988
ISSN:1388-9842
1879-0844
1879-0844
DOI:10.1002/ejhf.1436